Effect of Lifestyle Intervention on Mobilization of Fat Storage and Iron Deposition in Obesity

NCT ID: NCT06441409

Last Updated: 2025-08-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

160 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-04-15

Study Completion Date

2025-04-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to learn if calorie-restricted balanced diet could uniquely influence various fat storage pools and iron deposition and explore the relationships between fat or iron deposition loss in specific locations and glucose metabolism. The main questions it aims to answer are:

After lifestyle intervention, which part of the body shows the fastest fat mobilization? Which part shows the slowest fat mobilization? Which area's fat mobilization is most related to the alleviation of glucose metabolism? Is there a relationship between the fat deposition in organs and the iron deposition in organs?

Researchers will compare the liver fat, pancreatic fat, visceral fat, subscutaneous fat, liver and pancrease iron depositon after lifestyle intervention using self pre-and post-control .

Participants will:

Receive the lifestyle intervention in outpatient. Visit the clinic once after 6 months for checkups and tests. Keep a diary of their diet.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Fat mobilization status is assessed using magnetic resonance, while the relief of glucose metabolism is determined based on the results of the OGTT before and after life style intervention.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Liver Fat Fertility Disorders Life Style, Healthy Glucose Metabolism Disorders (Including Diabetes Mellitus)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Patients were intervened with lifestyle only.
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

open label

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

lifestyle intervention

Patients were intervened with lifestyle only and returned to clinic for tests in 6 months.

Lifestyle intervention included the diet and exercise. Diet was an energy-restricted balanced diet. Exercise requires 5 days a week and 30 minutes every day.

Group Type EXPERIMENTAL

Lifestyle intervention

Intervention Type BEHAVIORAL

Patients were intervened with lifestyle only and returned to clinic for tests in 6 months.

Lifestyle intervention included the diet and exercise. Diet was an energy-restricted balanced diet. Exercise requires 5 days a week and 30 minutes every day.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Lifestyle intervention

Patients were intervened with lifestyle only and returned to clinic for tests in 6 months.

Lifestyle intervention included the diet and exercise. Diet was an energy-restricted balanced diet. Exercise requires 5 days a week and 30 minutes every day.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age between 18 and 70 years
* have a BMI greater than 28.0 kg/m2
* exhibit abdominal obesity, defined as a waist circumference of at least 90 cm for men and 85 cm for women
* willing to undergo a 6-month lifestyle intervention

Exclusion Criteria

* For newly diagnosed patients with type 2 diabetes: those with fasting blood glucose ≥ 11.1 mmol/L, random blood glucose ≥ 16.7 mmol/L, or HbA1c ≥ 9.0%, or those exhibiting significant hyperglycemic symptoms, who need to start antidiabetic medication treatment immediately;
* a prior history of pancreatic diseases;
* combination of drug-induced hepatitis, autoimmune hepatitis, and viral hepatitis;
* with a definitive diagnosis of diabetes who have already started medication treatment;
* severe complications from type 2 diabetes or other significant diseases;
* usage of drugs affecting body weight, insulin sensitivity, or metabolic-associated fatty liver disease in the past three months (such as insulin, glucocorticoids, thiazolidinediones, metformin, SGLT-2 inhibitors, or GLP-1 receptor agonists);
* with malignant tumors;
* acute or chronic infection;
* with elevated transaminase levels of unknown cause;
* hemochromatosis;
* with iron deficiency anemia who are receiving iron supplementation;
* who have donated blood or received a transfusion within the past six months;
* who have experienced cardiovascular events within the past six months;
* with acute or chronic blood loss;
* alcohol dependence, defined as ethanol intake exceeding 140 g/week for men and 70 g/week for women;
* pregnant and lactating women.
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The Third Xiangya Hospital of Central South University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ping Jin

Role: STUDY_CHAIR

The Third Xiangya Hospital of Central South University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

the Third Xiangya Hospital of Central South University

Changsha, Hunan, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

No. 2022JJ40749

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

22218

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.